Performance of standardized patient reported outcomes developed for spondyloarthritis in primary and concomitant forms of fibromyalgia

Table 3 Baseline scores of different items of all female patients related to the diagnoses pFM or axSpA or PsA with cFM or without FM

	FM	axSpA-	p-value to FM	axSpA+	p-value to FM	p-value within axSpA	PsA-	p-value to FM	PsA+	p-value to FM	p-value within PsA
BADSAI	6.9 ± 1.4	5.3 ± 1.9	< 0.001	6.9 ± 1.4	0.886	0.009	---	---	---	---
ASDAS-CRP	3.3 ± 0.6	2.9 ± 0.8	0.019	3.7 ± 1.2	0.206	0.019	---	---	---	---
BASFI	6.4 ± 2.1	4.8 ± 2.5	0.002	7.1 ± 1.8	0.418	0.015	---	---	---	---
DAPSA	42.8 ± 17.4	---	---	---	---		34.8 ± 17.7	0.013	47.6 ± 19.9	0.238	0.023
FIQ	68.5 ± 13.6	51.9 ± 21.7	< 0.001	72.3 ± 13.7	0.362	0.005	56.6 ± 16.8	< 0.001	67.6 ± 11.3	0.725	0.01
LEI	3.9 ± 1.6	2.1 ± 1.8	< 0.001	3.3 ± 1.4	0.195	0.031	2.9 ± 1.9	0.001	3.5 ± 2.0	0.435	0.294
MASES	8.6 ± 3.0	3.9 ± 2.9	< 0.001	8.2 ± 2.9	0.639	< 0.001	5.2 ± 3.6	< 0.001	6.7 ± 3.3	0.04	0.117
SPARCC	9.3 ± 3.3	4.6 ± 3.3	< 0.001	7.7 ± 3.8	0.146	0.032	6.3 ± 3.4	< 0.001	7.9 ± 4.0	0.328	0.075

ISSN: 1478-6362